Dyslipidemia is associated with a poor prognosis of breast cancer in patients receiving neoadjuvant chemotherapy

BACKGROUND: Lipid metabolism disorders may be involved in the occurrence and development of breast cancer. This study aimed to investigate the serum lipid changes during neoadjuvant chemotherapy for breast cancer and the effect of dyslipidemia on the prognosis of breast cancer patients. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Youzhao, Lv, Minhao, Yuan, Peng, Chen, Xiuchun, Liu, Zhenzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985843/
https://www.ncbi.nlm.nih.gov/pubmed/36870942
http://dx.doi.org/10.1186/s12885-023-10683-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985843/
https://www.ncbi.nlm.nih.gov/pubmed/36870942
http://dx.doi.org/10.1186/s12885-023-10683-y

Ejemplares similares